Bacterial two-component signalling as a therapeutic target in drug design: Inhibition of NRII by the diphenolic methanes (bisphenols)

11Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Domagala, J. M., Alessi, D., Cummings, M., Gracheck, S., Huang, L., Huband, M., … Wold, S. (1998). Bacterial two-component signalling as a therapeutic target in drug design: Inhibition of NRII by the diphenolic methanes (bisphenols). Advances in Experimental Medicine and Biology. Kluwer Academic/Plenum Publishers. https://doi.org/10.1007/978-1-4615-4897-3_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free